In dissociated neuronal cultures the absence of spatial and temporal cues causes the emergence of mismatched synapses, where post-synaptic proteins of GABAergic synapses are in part apposed to glutamatergic pre-synaptic terminals and vice versa. This mismatch offers an opportunity to study the mechanisms that regulate correct apposition of preand post-synaptic elements. We report here that the IQ motif and Sec7 domain-containing protein 3 (IQSEC3; BRAG3; synArfGEF) specifically regulates the mislocalization of GABAergic post-synaptic density (PSD) proteins. Over-expression of IQSEC3 constructs harboring mutations that ablate Sec7 domain or IQ motif function revealed that IQSEC3 catalytic activity is involved in the control of apposition between the GABAergic PSD and glutamatergic terminals. Neurons coexpressing eGFP-gephyrin with IQSEC3 Sec7 mutant displayed a drastically increased fraction of mismatched eGFPgephyrin clusters compared to other IQSEC3 constructs. Along with eGFP-gephyrin, endogenous GABA A receptor cluster mismatching was increased by IQSEC3 Sec7 mutant overexpression. Conversely, GFP-PSD-95 clusters were unaffected by over-expression of any IQSEC3 construct. The GABAergic PSD mismatch phenotype was recapitulated by Arf6 dominant-negative mutant over-expression, suggesting that Arf6 activation by IQSEC3 is an essential step in this pathway. In addition, we provide biochemical evidence to confirm gephyrin/IQSEC3 interaction near the IQSEC3 IQ motif, which in turn binds calmodulin at low Ca 2+ concentrations.
Alignment of pre-synaptic terminals of each neurotransmitter with post-synaptic densities (PSD) containing the corresponding post-synaptic receptors along with scaffolding and effector proteins is a fundamental requirement for neurotransmission at chemical synapses. Most neurons in the mammalian CNS are innervated by axon terminals with a wide range of neurochemical compositions and synapses employing different neurotransmitter systems are often in close proximity. Yet, mismatched pre-and post-synaptic structures are virtually absent in vivo. Temporal differences in synapse formation between neurotransmitter systems do not fully account for correct apposition since synapse formation and elimination are life-long processes (Tyzio et al. 1999; Khazipov et al. 2001; Caroni et al. 2014) . Molecular mechanisms must therefore contribute to the fidelity of apposition between neurotransmitter-specific preand post-synaptic elements.
Synapse formation is initiated by cell adhesion through homophilic trans-synaptic adhesion complexes, which are not neurotransmitter-specific (Missler et al. 2012) . Differentiation of post-synaptic structures into specializations suited for a given neurotransmitter released from pre-synaptic terminals is achieved after initial contact formation by signaling molecules, of which only few are known to date. One of the best described mechanisms of neurotransmitterspecific induction of post-synaptic differentiation is dependent on alternative splicing of neurexin and neuroligin. Isoform-specific splice inserts in neuroligin extracellular domains interact with neurexins, promoting neurotransmitterspecific pre-synaptic differentiation. While other transsynaptic molecules are known to be involved in promotion of neurotransmitter-specific differentiation, factors responsible for suppressing mismatched synaptic structures were not described thus far.
Although in vivo misalignment of pre-and post-synaptic structures is very rare (but see Fritschy et al. 2006) , formation of mismatched synapses is common in dissociated neuronal cultures (Rao et al. 2000; Brunig et al. 2002; Christie et al. 2002) . Both GABA A receptors (GABA A R) and a-amino-3-hydroxy-5-methylisoxazole-4-propionate receptors are found in apposition to inappropriate axon terminals. Appearance of mismatched synapses in dissociated cultures is a consequence of the lack of spatial and temporal cues that guide synapse formation in vivo. However, although the altered situation in dissociated neurons does not directly correspond to the situation in vivo, the presence of mismatched synapses in neuronal cultures provides an opportunity to study the molecular underlinings of synapse validation. The observation that the fraction of mismatched synapses in primary neurons is reduced with time in culture suggests that correction mechanisms ensure appropriate apposition after synapse formation. Since pharmacological activation of GABA A or NMDA receptors influences the abundance of mismatched synapses, such mechanisms are likely activity-dependent (Anderson et al. 2004) .
IQ motif and Sec7 domain-containing protein 3 (IQSEC3; BRAG3; synArfGEF) is a guanine nucleotide exchange factor (GEF) for small GTPases of the ADP-ribosylation factor (Arf) family and is strongly expressed in the brain (Kikuno et al. 1999) . The protein was first described as part of the glutamatergic PSD because of immunoreactivity in the PSD fraction and the presence of a C-terminal PDZ-domainbinding motif (Inaba et al. 2004) . Subsequent investigations concluded that IQSEC3 is principally located at GABAergic post-synaptic sites, on the basis of immunohistochemical analyses by light and electron microscopy and because of its binding to dystrophin (Fukaya et al. 2011; Sakagami et al. 2013) . Like all Arf GEFs, IQSEC3 contains a catalytic Sec7 domain. The specificity of its GEF function is still unclear, since rat IQSEC3 showed activity for Arf6 but not Arf1, whereas the opposite was reported for the human homolog (Hattori et al. 2007; Fukaya et al. 2011) . Interestingly, the close IQSEC3 homologs IQSEC1 and IQSEC2 are located in the glutamatergic PSD and regulate endocytosis of GluA2-and GluA1-containing a-amino-3-hydroxy-5-methylisoxazole-4-propionate receptors, respectively (Scholz et al. 2010; Myers et al. 2012) . IQSEC3 functions at the synapse were not yet described but the nearly identical domain structure of IQSEC3 and its homologs suggests parallels in the role of IQSEC3 at the GABAergic PSD. Notably, all three homologs contain an IQ motif, which is known to bind calmodulin in a Ca 2+ -dependent manner, and might thereby tie catalytic function to synaptic activity also in IQSEC3 (B€ ahler and Rhoads 2002) .
Here, we explored the molecular mechanisms governing the correct alignment of pre-and post-synaptic structures in primary neuronal cultures. In particular, we addressed the question whether a post-synaptic protein like IQSEC3 is capable of regulating mismatched post-synaptic proteins and whether such regulation is neurotransmitter specific. By taking an over-expression approach using various mutated and truncated forms of IQSEC3, we report that the catalytic function of IQSEC3 specifically controls misapposition between proteins of the GABAergic PSD and glutamatergic axon terminals. Similar alterations in mismatched synapses were found with over-expression of Arf6 mutants, suggesting that activation of Arf6 by IQSEC3 is an essential step in this pathway. Colocalization and biochemical interaction with gephyrin validated the proximity of IQSEC3 to GABAergic post-synaptic structures and the finding of Ca 2+ -dependent calmodulin binding to IQSEC3 supported the notion that regulation of mismatched synapses is an activity-dependent process. Taken together, our experiments uncovered a neurotransmitter-specific process aimed at controlling formation of mismatched synapses in primary hippocampal cultures.
Materials and methods
Constructs pCIneo-FLAG-IQSEC3 plasmid was provided by Dr. Hiroyuki Sakagami and encodes FLAG-tagged rat IQSEC3 (NCBI NM_207617.1). The insert was PCR amplified and subcloned into the same vector using restriction sites EcoRI and NotI to avoid double insertion and remove part of IQSEC3 3 0 -UTR which was present in the original plasmid. Site-directed mutagenesis of the resulting plasmid was achieved through whole-plasmid amplification using point-mutated primers with Pfu Ultra Hotstart DNA Polymerase (Agilent, Santa Clara, CA, USA). The E749K mutation was selected based on abolition of catalytic activity of IQSEC2 by a homologous mutation (E849K) (Myers et al. 2012) , as well as in ARNO (E156K) (Cherfils et al. 1998; Mossessova et al. 1998 Western blotting HEK cells were rinsed carefully with ice-cold phosphate-buffered saline (PBS) and lysed in 50 mM Tris (pH 7.6), 120 mM NaCl, 0.5% NP-40 containing protease inhibitors [Complete Mini Protease Inhibitor Cocktail (Roche) ] by shaking on a compensator for 20 min at 4°C. Lysates were centrifuged at 33 000 g for 20 min at 4°C and supernatants were stored at À80°C. Samples were mixed with Laemmli buffer, boiled at 90°C and run on tris-glycine polyacrylamide gels. Proteins were transferred to polyvinylidene fluoride membranes. Primary antibodies were incubated in Tris-buffered saline with 0.05% Tween 20 (TBST) including 5% Western Blocking Solution (Roche) ON at 4°C. Membranes were washed five times in TBST. Horseradish peroxidase-coupled donkey secondary antibodies (1 : 20 000) were incubated for 1 h at 20-22°C and membranes were washed again five times in TBST. SuperSignal West Pico Chemiluminescent Substrate (Thermo Fisher Scientific) was applied and membranes were developed on X-ray film (Fujifilm, Tokyo, Japan).
Immunoprecipitation HEK cell lysates were incubated with 1 lg of immunoprecipitation antibody on a rotator for 3 h at 4°C. Protein G-agarose beads in EBC buffer (50 mM Tris, 120 mM NaCl, 0.5% NP-40) were added to lysates and the samples rotated again for 1 h at 4°C. After a wash in high salt buffer (50 mM Tris, 500 mM NaCl, 1% NP-40), the beads were washed twice with EBC buffer. Immunoprecipitates were eluted from beads by heating to 90°C in Laemmli buffer for 3 min.
Arf6 activation assay HEK293T cells were transfected with wild-type FLAG-IQSEC3 or with FLAG-IQSEC3 E749K. The Arf6 activation assay was performed as recommended by the vendor (Cytoskeleton Inc, Denver, CO, USA; Cat. # BK033-S). For control, wild-type lysates were incubated with GDP or csGTP for 15 min at 37°C and the reaction was stopped using the stop buffer provided by the vendor. The GGA3-protein-binding domain (PBD) beads coupled to the Arf6-PBD of the effector protein GGA3 were added to all lysates for 45 min to enrich for activated Arf6 from the lysate. After washing twice in wash buffer, the denatured samples were loaded onto sodium dodecyl sulfate gels for WB analysis using the Arf6 monoclonal antibody provided by the vendor.
Calmodulin-binding assay HEK cells transfected with FLAG-tagged IQSEC3 constructs were lysed in the presence of either 2 mM CaCl 2 or 2 mM EGTA. To avoid decreasing CaCl 2 or EGTA concentrations in further steps in the assay, all solutions before elution contained either 2 mM CaCl 2 or 2 mM EGTA. After sparing a sample of each lysate as loading control, lysates were mixed with Calmodulin Sepharose beads (GE Halthcare, Little Chalfont, UK) and incubated on a rotator for 3 h at 4°C. Beads were washed three times in 50 mM Tris, 150 mM NaCl, 1% Triton X-100 containing protease inhibitors [Complete Mini Protease Inhibitor Cocktail (Roche)]. For elution, beads were incubated in 50 mM Tris, 150 mM NaCl containing high concentration of the opposite condition (10 mM EGTA or 10 mM CaCl 2 ) for 30 min at 20-22°C on a rotator. Supernatant containing pulldown proteins was mixed with Laemmli buffer, heated to 90°C for 3 min and used for western blot analysis.
Primary hippocampal cultures
Experiments were conducted in accordance with Swiss law on animal experimentation and the European Parliament Directive of 22 September 2010 on the protection of animals used for scientific purposes (2010/63/EU) and were approved by the cantonal veterinary office of Zurich. All measures were taken to minimize pain and suffering of the experimental animals. Specifically, pregnant Wistar rats (Charles River Laboratories, Germany; RRID:RGD_2308816) were anesthetized at E18 with isoflurane (Attane; Piramal, Mumbai, India) (5% in air) until disappearance of pain reflexes (paw pinch) and killed by cervical dislocation. Embryonic hippocampi were dissected on ice. Care was taken not to contaminate hippocampi with neocortical cells. After digestion of tissue with 0.5 mg/mL papain and 10 lg/mL DNase I for 15 min at 37°C, cells were dissociated by gently mixing with a Pasteur pipette. Cells were diluted in DMEM + GlutaMAX-I (Thermo Fisher Scientific) including 10% FCS, 2 mM L-glutamine, 0.1 mg/mL gentamicin and 2.5 lg/mL fungizone and plated on poly-L-lysinecoated coverslips at a density of approximately 30 000 cells per coverslip. After 2 h incubation at 37°C/5% CO 2 , coverslips were transferred to 12-well dishes containing cell culture medium [15 mM HEPES, 15% NU serum (Corning Incorporated, Corning, NY, USA), 0.45% glucose, 1 mM Na-pyruvate, 2 mM L-glutamine and B27 (19; Thermo Fisher Scientific) in Minimum Essential Medium (Thermo Fisher Scientific)] and returned to the incubator until use.
Transfection of cultured neurons
Opti-MEM medium (Thermo Fisher Scientific) was mixed with 500 ng of endotoxin-free DNA per plasmid and coverslip to be transfected. After a 5 min incubation of lipofectamine 2000 (Oz Biosciences, Marseille, France) in Opti-MEM, the mix was added to the DNA solution for a final dilution of 1 : 30. Magnetofection reagent (Oz Biosciences) was added at a final dilution of 1 : 300 to the DNA/lipofectamine 2000 mixture and the solution was incubated at 20-22°C for 15 min. The transfection solution was added dropwise to coverslips in 1 mL of cell culture medium and cells incubated at 37°C/5% CO 2 for 40 min. Coverslips were transferred to 1 mL of conditioned medium and returned to the incubator until use.
Immunocytochemistry
Following a quick rinse in PBS to remove residual cell culture medium, cells were fixed immediately in 4% paraformaldehyde (PFA) in PBS for 10 min at 20-22°C. Coverslips were rinsed again in PBS and cells permeabilized in PBS containing 10% normal goat serum and 0.15% Triton X-100 for 5 min. Cells were incubated with primary antibodies diluted in PBS containing 10% normal goat serum for 90 min at 20-22°C. After washing coverslips three times in PBS for 5 min under agitation, cells were incubated with secondary antibodies diluted in PBS for 45 min. Secondary antibodies were raised in goat and were coupled to the following fluorophores: Alexa Fluor 488 (1 : 1000; Jackson ImmunoResearch, West Grove, PA, USA), Cy3 (1 : 500; Jackson ImmunoResearch), Alexa Fluor 647 (1 : 1000; Jackson ImmunoResearch). Coverslips were washed three times in PBS for 5 min under agitation, dried and mounted with Fluorescence Mounting Medium (Dako, Carpinteria, CA, USA).
Image acquisition and analysis
All specimens from neuronal cultures were imaged using confocal laser scanning microscopy (LSM 700 and LSM 710; Carl Zeiss, Oberkochen, Germany). Images were taken using a 409 objective with a numerical aperture of 1.4 and had a pixel size of 112 9 112 nm 2 . For quantification of synaptic markers, individual dendrites were framed by a region of interest with 2.5 lm thickness and clusters (representing pre-or post-synaptic protein aggregates) were quantified by an automated macro in ImageJ (NIH, Bethesda, MD, USA). To determine apposition of pre-and post-synaptic clusters, pre-synaptic marker size was enlarged by 1 pixel and colocalization with post-synaptic markers sampled. All imaging and quantification parameters were kept constant between conditions.
Experimental design and statistical analysis
This study was not pre-registered because of its explorative nature. All plasmids used for one given experiment were transfected in cells derived from a single cell preparation (pooled from all embryos prepared) and all experiments were repeated at least three times. Coverslips were selected at random prior to transfection. In each experiment, data were collected from multiple dendrites and regions of interest in each cell. Statistical analysis of cluster density values was performed with averaged data points from individual cells; cluster size values were compared from pooled cluster data from all cells per group (Tables 1 and 2 ). No power analysis was performed owing to the nested nature of the data (coverslips-cells-regions of interest). All quantifications involving mutant constructs were performed by an observer unaware of the type of construct transfected.
Statistical tests were performed using Prism software (GraphPad, La Jolla, CA, USA). Data points in cluster density graphs represent individual cells and whiskers indicate standard error of the mean. One-way ANOVA and Kruskal-Wallis tests were used for analyzing differences in cluster density and cluster size, respectively. The threshold for significance was set at p < 0.05.
Results
IQSEC3 was described as a dystrophin-interacting protein because of its capability to bind dystrophin WW domains and because of the colocalization of both proteins in primary hippocampal neurons (Fukaya et al. 2011) . Immunohistochemical analyses of brain and retina sections, however, revealed a distribution pattern reminiscent of more broadly distributed proteins of the GABAergic PSD, such as gephyrin (Fukaya et al. 2011; Sakagami et al. 2013) . For this reason, we probed IQSEC3-gephyrin interaction in heterologous cells. According to known functions of domains found in IQSEC3 homologs, mutations and truncations of FLAG-tagged IQSEC3 were generated and co-expressed with eGFP-tagged gephyrin in HEK293T cells (Fig. 1) . Gephyrin was found to co-immunoprecipitate with wild-type IQSEC3. Mutation of the IQ motif (I318A/Q319A/ R323A), a serine residue undergoing phosphorylation (S348), the catalytically essential glutamate residue in Sec7 domain (E749K) or the dystrophin-interacting PP motif (P1165A/P1166A/Y1168A) had no effect on gephyrinbinding efficiency (Fig. 1b and c) (Cherfils et al. 1998; Trinidad et al. 2006; Fukaya et al. 2011; Myers et al. 2012) . Interaction with gephyrin was also retained when using a VGAT-apposed
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VGAT-apposed IQSEC3 construct lacking the pleckstrin homology (PH) domain (Fig. 1b) . However, the deletion of the first Nterminal 181 amino acids in IQSEC3 caused a drastic reduction in eGFP-gephyrin detected in the immunoprecipitate ( Fig. 1c and e) . In order to determine the minimal domain requirement of IQSEC3 for gephyrin interaction, various IQSEC3 truncations were probed for the ability to co-immunoprecipitate gephyrin. Surprisingly, the coiled coil 1 (CC1)-containing N-terminal part alone was not able to bind gephyrin, but the domain containing the IQ motif was sufficient for gephyrin binding (Fig. 1d) . Within the IQ motif-containing domain, the region close to the IQ motif was found to bind gephyrin, whereas the region close to the Sec7 domain did not (Fig. 1e) . The expression of an intermediate region (IQ fragment 2) and of the isolated Sec7 domain was not strong enough to assess binding capability to gephyrin. Together, these results show that IQSEC3 binds to gephyrin near the IQ motif and that the Nterminal CC domain is required for efficient binding.
To verify that the E749K mutation abolishes catalytic activity of Sec7 mutant, an Arf6 activation assay was used in transfected HEK cells. As expected, levels of activated Arf6 pulled down by Arf6-PBD beads were much lower when Sec7 mutant was over-expressed compared to wild-type, demonstrating that the E749K mutation interferes with the catalytic activity of IQSEC3 (Fig. 2a) . Because co-IP results pointed to an interaction of gephyrin with IQSEC3 near its IQ motif, the functional importance of the IQ motif in IQSEC3 was examined using a calmodulin-binding assay. IQSEC3 constructs were expressed in HEK293T cells and lysates incubated with calmodulin-bound beads either in the presence of 2 mM Ca 2+ or 2 mM EGTA. Indeed, binding of IQSEC3 to calmodulin was observed in low Ca 2+ conditions (Fig. 2b) . This interaction was completely abolished for the IQSEC3 IQ mutant, but not for the Sec7 mutant or the DN construct, confirming that binding takes place at the IQ motif.
Similar to glutamate receptor regulation by IQSEC3 homologs IQSEC1 and IQSEQ2, the role of IQSEC3 at GABAergic PSD might depend on its catalytic function (Scholz et al. 2010; Myers et al. 2012) . To test this possibility, FLAG-tagged IQSEC3 constructs were overexpressed in primary hippocampal neurons together with eGFP-gephyrin at DIV 8 and analyzed at DIV 15 (DIV 8 + 7). Over-expressed IQSEC3 variants largely colocalized with eGFP-gephyrin but were also diffusely distributed in dendrites and the cell soma (Fig. 3a) . Cultures were labeled with anti-VGAT or anti-VGluT1 + 2 antibodies to distinguish between GABAergic synapses and mismatched synapses (gephyrin clusters apposed to glutamatergic terminals). This approach revealed a dramatic elevation of eGFPgephyrin clusters non-apposed to VGAT-positive terminals in cells over-expressing IQSEC3 Sec7 mutant in comparison to cells transfected with empty vector or with other IQSEC3 constructs ( Fig. 3a and b) . A reduction in the percentage of VGAT-apposed gephyrin clusters paralleled the cluster density results in Sec7 mutant-over-expressing cells. The density of eGFP-gephyrin clusters apposed to VGluT1 + 2-positive terminals was increased to a similar extent as the VGAT non-apposed gephyrin cluster density, demonstrating that many VGAT non-apposed clusters were mismatched (Fig. 3c) . Sec7 mutant-transfected cells also exhibited an increase in overall eGFP-gephyrin cluster density, consistent with the notion that Sec7 mutant over-expression promotes mismatched gephyrin clustering (Fig. 3d) . Surprisingly, over-expression of wild-type IQSEC3 and IQ motif mutant did not lead to changes in overall eGFP-gephyrin cluster density or in apposition of eGFP-gephyrin clusters. Finally, eGFP-gephyrin cluster size was reduced in cells transfected with any of the IQSEC3 constructs, indicating that this reduction is caused by binding of constructs to gephyrin and not by IQSEC3 catalytic activity (Fig. 3e) . IQSEC3 exhibits a PDZ domain-binding motif at the Cterminal end and was first described as a protein enriched in the PSD of glutamatergic synapses (Inaba et al. 2004) . The observed phenotype could be a manifestation of a more general function of IQSEC3 in synapse validation, both for GABAergic and glutamatergic PSD proteins. For this reason, we co-expressed IQSEC3 constructs with GFP-PSD-95 and examined apposition to presynaptic markers (Fig. 4) . In contrast to eGFP-gephyrin, GFP-PSD-95 did not In all experiments, constructs were expressed in HEK293T cells and lysates used for co-IP using mouse anti-FLAG antibody bound to agarose beads. Two negative controls were employed to exclude unspecific binding. Anti-FLAG antibody was replaced by unspecific mouse IgG but both constructs were expressed. In addition, the construct to be immunoprecipitated was not expressed but immunoprecipitation antibody was present. preferentially colocalize with FLAG-IQSEC3 constructs when co-expressed (Fig. 4a) . Also, IQSEC3 catalytic function did not affect the density of mismatched (VGATapposed) PSD-95 clusters. GFP-PSD-95 clusters were about five times more frequently apposed to VGluT1 + 2-than to VGAT-positive terminals in all conditions (Fig. 4a-d) . In addition, GFP-PSD-95 cluster size was not affected by overexpression of IQSEC3 constructs (Fig. 4e) . IQSEC3 catalytic function thus seems to be specifically required for regulation of presynaptic terminal apposition to the GABAergic PSD.
Regulation of gephyrin presynaptic apposition by IQSEC3 raises the question whether such control is exerted through trans-synaptic signaling or whether purely post-synaptic mechanisms are involved. Quantification of presynaptic marker density revealed that innervation density is not affected by IQSEC3 over-expression (Fig. 5) . In terms of fraction of presynaptic markers apposed to eGFP-gephyrin, only VGluT1 + 2 puncta exhibited an increase upon Sec7 mutant over-expression. This observation is consistent with the notion that IQSEC3 has a post-synaptic role in regulation of mismatched synapses.
To exclude the possibility that IQSEC3 function is restricted to down-regulation of gephyrin at mismatched sites, over-expression experiments were repeated without eGFP-gephyrin co-expression. Instead, GABA A R c2 subunit was immunolabeled to assess consequences of IQSEC3 wild- IQSEC3 constructs were over-expressed in HEK293T cells and lysates used for calmodulin pull-down assay in the presence of 2 mM CaCl 2 or 2 mM EGTA. Fig. 3 The catalytic function of IQSEC3 regulates apposition of gephyrin to pre-synaptic terminals. FLAG-tagged IQSEC3 constructs or an empty vector were co-expressed with eGFP-gephyrin in primary hippocampal neurons at DIV 8 and apposition to VGAT or VGluT1 + 2 immunofluorescent puncta assessed at DIV 15. (a) Representative images of dendrites of transfected cells. FLAG immunoreactivity is shown in cells co-labeled for VGAT. IQSEC3 Sec7 mutant-overexpressing cells exhibit an increased amount of VGAT-non-apposed eGFP-gephyrin clusters (arrowheads) in comparison to all other constructs. VGluT1 + 2-apposed eGFP-gephyrin clusters (arrows) are also more abundant in cells over-expressing Sec7 mutant. (b) Quantification of eGFP-gephyrin VGAT apposition. VGAT-apposed eGFP-gephyrin cluster density was not significantly different between constructs. In contrast, VGAT-non-apposed eGFP-gephyrin clusters displayed an increased density in Sec7 mutant-expressing cells compared to all other constructs, resulting in a decreased percentage of VGAT-apposed eGFP-gephyrin clusters. (c) Quantification of eGFPgephyrin VGluT1 + 2 apposition. VGluT1 + 2-apposed eGFPgephyrin cluster density was increased by over-expression of Sec7 mutant but in VGluT1 + 2-non-apposed eGFP-gephyrin clusters no significant differences were found between groups. The increase in VGluT1 + 2-apposed eGFP-gephyrin cluster density in Sec7 mutantexpressing neurons is reflected in a higher percentage of VGluT1 + 2-apposed eGFP-gephyrin clusters. (d) Quantification of total dendritic eGFP-gephyrin cluster densities. Over-expression of IQSEC3 Sec7 mutant led to an increase in eGFP-gephyrin cluster density, whereas IQSEC3 wild-type or IQ mutant did not significantly change eGFPgephyrin cluster density. (e) Quantification of overall eGFP-gephyrin cluster size in cells co-expressing IQSEC3 constructs. Compared to empty vector, all IQSEC3 constructs caused a small but statistically significant reduction in cluster size when co-expressed with eGFPgephyrin. In box plots, lines, crosses, boxes, and whiskers represent median, mean, 25-75 percentile, and 10-90 percentile, respectively. Data points represent individual cells. **p < 0.01, ***p < 0.001; (see Tables 1 and 2 for results of statistical analyses).
type and Sec7 mutant over-expression for GABA A R apposition (Fig. 6 ). Neighboring untransfected dendrites were used in both conditions as internal controls. As with eGFPgephyrin co-expression, Sec7 mutant-transfected cells exhibited a higher proportion of mismatched c2 subunit clusters (apposed to VGluT1 + 2-positive terminals) than untransfected dendrites. Along with gephyrin apposition, IQSEC3 catalytic function thus contributes to regulate the apposition of GABA A R clusters to neurotransmitter-specific presynaptic terminals. If Arf6 is the target of IQSEC3 catalytic activity for regulation of GABAergic PSD apposition, abolition of Arf6 activity alone should replicate the apposition phenotype of the Sec7 mutant. Over-expression of Arf6 in its wild-type form, and to a larger extent over-expression of constitutively active (CA; Q67L) or dominant negative (DN; T27N) Arf6 mutants, affects neuronal morphology (Hernandez-Deviez et al. 2002; Miyazaki et al. 2005) . Neurite and spine outgrowth seem to be regulated by Arf6, since these processes are promoted by Arf6 DN and inhibited by Arf6 CA over-expression, respectively. For this reason, primary hippocampal neurons over-expressing HA-tagged Arf6 variants were probed with antibodies to GABA A R a2 subunit to ensure that formation of the GABAergic PSD is not affected by morphological changes. The a2 subunit was selected for analysis, rather than c2, because it more distinctly labels post-synaptic GABA A R clusters. As expected, GABA A R a2 subunit clusters were observed on dendrites of Arf6-expressing neurons to the same extent as on non-transfected neurons (Fig. 7a) . To facilitate the assessment of GABAergic PSD abundance and apposition patterns, eGFP-gephyrin was co-expressed with Arf6 constructs. As expected from observations of GABA A R a2 subunit clustering, the overall density of eGFP-gephyrin clusters did not change upon Arf6 construct over-expression (Fig. 7b) . Analysis of presynaptic apposition, however, uncovered that in Arf6 DN-expressing cells a smaller fraction of eGFP-gephyrin clusters was correctly apposed and a larger fraction was present in mismatched synapses, both compared to Arf6 CA-expressing cells and to cells expressing eGFP-gephyrin only (Fig. 7c-d) . Similar to results from IQSEC3 over-expression experiments, these alterations were caused by an increase in the proportion of mismatched gephyrin clusters apposed to VGluT1 + 2-positive terminals. Therefore, Arf6 activity is sufficient for regulation of apposition between the GABAergic PSD and presynaptic terminals, indicating that Arf6 activation by IQSEC3 is involved in this process.
The N-terminal CC1-containing domain necessary for gephyrin interaction in IQSEC3 has been demonstrated to be essential for homomultimerization in IQSEC2 (Myers et al. 2012) . This line of evidence suggests a relationship between IQSEC3 homomultimerization and gephyrin interaction. However, the N-terminal CC1-containing domain is dispensable for homomultimerization in IQSEC3, as assessed by co-immunoprecipitation of mCherry-tagged with FLAG-tagged IQSEC3 variants (Fig. 8a ). Of all constructs tested, only mutation of S348 to alanine modulated the proportion of co-immunoprecipitated mCherrytagged IQSEC3, raising the possibility that phosphorylation of this residue is involved in regulating IQSEC3 homomultimerization. FLAG-tagged IQSEC3 over-expressed in primary hippocampal neurons formed large somatic aggregates, reminiscent of aggregates formed by over-expressed eGFPgephyrin (Fig. 8b) . These somatic IQSEC3 aggregates were consistently immunopositive for endogenous gephyrin. Deletion and mutation constructs of IQSEC3 were tested for their ability to form somatic aggregates. Strikingly, the deletion of the N-terminus abolished the majority of somatic aggregates and so did mutation of the IQ motif. Mutation of S348, the Tables 1 and 2 for results of statistical analyses). PSD, post-synaptic density. *p < 0.05; (see Table 1 for results of statistical analyses).
catalytic glutamate residue in the Sec7 domain, the PP motif or deletion of the PH domain did not influence somatic IQSEC3 aggregation. Since individual domains did not form aggregates, somatic aggregates might be formed only by IQSEC3 constructs retaining gephyrin and calmodulin interaction capability. Together, these results suggest that IQSEC3 function is mediated by interactions with gephyrin and calmodulin.
Discussion
Our study of IQSEC3 function in primary hippocampal neurons provides evidence for control of mismatched GABAergic PSD proteins by IQSEC3, in a mechanism that likely depends on Ca 2+ -calmodulin signaling. Catalytic activity is implicated in this regulation by the strong effect of Sec7 domain mutation as well as the recapitulation of the misapposition phenotype by Arf6 over-expression. IQSEC3 function is restricted to mis-apposed GABAergic PSDs since PSD-95 apposition to GABAergic or glutamatergic terminals was not affected, suggesting that the interaction with gephyrin might be implicated in regulating IQSEC3 function. Moreover, Ca 2+ -dependent calmodulin binding and the finding that correctly matched GABAergic PSDs were unaffected in all experiments strongly suggests that proximity to glutamatergic structures enables this function of IQSEC3. Gephyrin binding near the calmodulin-binding site Fig. 5 Fraction of mismatched glutamatergic pre-synaptic terminals but not innervation density is affected by IQSEC3 catalytic function. (a) Quantification of VGAT puncta densities and percentage of VGAT puncta apposed to eGFP-gephyrin. Co-expression of IQSEC3 constructs had no statistically significant effect on puncta density or percentage of apposition to eGFP-gephyrin. (b) Quantification of VGluT1 + 2 puncta densities and percentage of VGluT1 + 2 puncta apposed to eGFP-gephyrin. Percentage of VGluT1 + 2 puncta apposed to eGFP-gephyrin was increased in Sec7 mutant-overexpressing cells compared to all other groups but absolute VGluT1 + 2 densities were unaffected by IQSEC3 construct co-expression. Data points represent individual cells. ***p < 0.001; (see Table 1 for results of statistical analyses).
and calmodulin binding were found to be essential for somatic aggregation of over-expressed IQSEC3. This observation points to a mechanism by which IQSEC3 undergoes conformational changes upon neuronal activity and gephyrin binding to regulate mismatched GABAergic PSD proteins.
A physiologically relevant interaction of IQSEC3 with gephyrin is suggested by several findings. First, co-IP experiments in heterologous cells revealed binding that depended on domains with known functions. Second, coexpression of both proteins in primary neurons led to extensive colocalization in all subcellular domains. Third, somatic IQSEC3 aggregates formed upon over-expression were immunopositive for endogenous gephyrin. These observations are in line with the extensive colocalization of IQSEC3 with markers of GABAergic synapses reported in various parts of the CNS (Fukaya et al. 2011; Sakagami et al. 2013) . Dystrophin interaction may be involved in accumulating IQSEC3 at dystrophin-containing synapses. However, the restricted dystrophin distribution in cortical areas excludes an obligatory role for dystrophin in IQSEC3 clustering (Lidov et al. 1990; Knuesel et al. 1999) . Along the same lines, localization of IQSEC3 containing mutated PP motif, which is necessary for dystrophin interaction, did not differ from wild-type and IQSEC3 clustering was virtually unaffected in the hippocampus of mice with pyramidal cell-specific loss of the dystrophin-glycoprotein complex (Fruh et al. 2016) . Gephyrin binding to IQSEC3 was reported on the basis of yeast-two-hybrid and co-IP experiments and also identified the IQ motif area as the minimally required area for interaction (Um et al. 2016) . Furthermore, gephyrin down-regulation in primary neurons caused a reduction in IQSEC3 clustering, arguing that this interaction is necessary for IQSEC3 synaptic localization. Substantial evidence has thus accumulated that IQSEC3 is enriched in the GABAergic PSD because of specific gephyrin interaction near the IQ motif.
Paradoxically, Um et al. (2016) have found an overall increase in gephyrin and GAD67 puncta density upon IQSEC3 over-expression, an effect which was dependent on gephyrin binding as well as on IQSEC3 catalytic activity. The reasons for the discrepancy to our results are not clear, since the same isoform of rat IQSEC3 was used in primary hippocampal cultures. Still, the use of the chicken beta-actin enhancer by Um et al. and the resulting strong overexpression of IQSEC3 might explain some of the differences. None of our experiments have yielded results that implicate IQSEC3 in the regulation of correctly apposed GABAergic proteins, despite the preferential GABAergic localization of IQSEC3. Further experiments will have to clarify whether IQSEC3 can contribute to overall GABAergic synapse development, and under what conditions.
Interaction with gephyrin might reflect a mechanism to target IQSEC3 to the GABAergic PSD rather than an interaction implicating direct gephyrin regulation. Indeed, gephyrin binding might even have an inhibitory effect on IQSEC3 catalytic activity, since IQSEC3 seems to be catalytically inactive in correctly apposed GABAergic PSDs. Other factors must be present at mismatched sites which promote IQSEC3 activity. Ca 2+ is a likely candidate to take this role, because of calmodulin binding near the gephyrin-binding site in low Ca 2+ conditions. The release of calmodulin from IQSEC3 at high Ca 2+ concentrations might enable an active conformational state allowing activation of Arf6 in the mismatched GABAergic PSD. Involvement of calmodulin in formation of such an active state would also account for the fact that neuronal activity was implicated in the fidelity of GABAergic apposition (Anderson et al. 2004) . Mutation of S348 to alanine increased the capacity of IQSEC3 to multimerize but did not directly affect gephyrin binding in co-IP experiments. Since this residue was found to be phosphorylated in PSD fraction (Trinidad et al. 2006) , it will be important to clarify whether S348 phosphorylation serves to regulate IQSEC3 catalytic activity.
The fact that Arf6 catalytic mutants replicated the misapposition phenotype of the Sec7 mutant strongly suggests that (c) Representative images of dendrites of cells transfected with IQSEC3 constructs (upper panels; FLAG immunolabeling shown) and untransfected neighboring dendrites (lower panels) immunolabeled for VGluT1 + 2. Note the high abundance of GABA A R c2 subunit clusters apposed to VGluT1 + 2 puncta (arrows) in dendrites of cells over-expressing Sec7 mutant. (d) Quantification of GABA A R c2 subunit cluster VGluT1 + 2 apposition. Sec7 mutant-transfected cells showed significantly higher density of VGluT1 + 2-apposed GABA A R c2 subunit clusters compared to untransfected cells and to cells transfected with wild-type IQSEC3. The increase in VGluT1 + 2-apposed cluster density is mirrored by a higher percentage of VGluT1 + 2-apposed clusters. Data points represent individual cells. *p < 0.05, **p < 0.01, ***p < 0.001; (see Table 1 for results of statistical analyses). Fig. 7 Arf6 is involved in regulation of gephyrin pre-synaptic apposition. (a) GABA A R clusters are present on neurons over-expressing Arf6 constructs. Primary hippocampal neurons were transfected with HA-tagged Arf6 wild-type, constitutively active (CA) mutant or dominant-negative (DN) mutant and GABA A R clustering assessed by a2 subunit immunolabeling. (b) Quantification of total eGFP-gephyrin cluster densities in cells co-expressing Arf6 constructs or expressing eGFP-gephyrin alone. Primary hippocampal cultures were transfected at DIV 8 and cells analyzed at DIV 15. Co-expression of Arf6 constructs had no effect on eGFP-gephyrin cluster density. (c) Representative images and quantifications of eGFP-gephyrin apposition to VGAT. Cells co-expressing HA-Arf6 DN displayed a higher density of VGAT-non-apposed clusters and a lower percentage of VGAT-apposed clusters than cells co-expressing HA-Arf6 CA. Arrowheads indicate eGFP-gephyrin clusters not apposed to VGAT. (d) Representative images and quantifications of eGFP-gephyrin apposition to VGluT1 + 2. Cells co-expressing HA-Arf6 DN displayed a higher density and percentage of eGFP-gephyrin clusters apposed to VGluT1 + 2 than cells co-expressing HA-Arf6 CA. Arrows indicate eGFP-gephyrin clusters apposed to VGluT1 + 2. Data points represent individual cells. *p < 0.05, **p < 0.01, ***p < 0.001; (see Table 1 for results of statistical analyses).
Arf6 acts as a substrate of IQSEC3 in this context. Arf6 is also the target of IQSEC1 and IQSEC2, leading to the internalization of GluA2 and GluA1 subunits, respectively. In order for IQSEC3 to achieve GABAergic PSD-specific regulation, activation of Arf6 would have to be restricted to GABAergic PSD-containing nanodomains. It is unclear how this specificity is ensured in mismatched synapses, presumably containing glutamatergic PSD proteins in addition to GABAergic PSD proteins, but spatial restriction of IQSEC3 to specific subdomains of the PSD might be one level of control. Arf6 is a membrane-bound GTPase which has diverse functions in neurons and is controlled by a multitude of GEF and GTPase-activating proteins (Jaworski 2007) . Downstream effectors of Arf6 regulate actin dynamics and both clathrin-dependent and -independent plasma membrane endocytosis. Therefore, direct regulation of gephyrin clustering, as well as regulation of PSD proteins through internalization of GABA A Rs, are possible consequences of IQSEC3-mediated activation of Arf6, which might eventually lead to the elimination of a mismatched synapse.
The absence of spatial and temporal cues is likely the main underlying cause for the formation of mismatched synapses in primary neuronal cultures. Therefore, it is unclear whether the regulation of misapposition by IQSEC3 has a physiological relevance in vivo. However, it is conceivable that formation of mismatched synapses by loss of guidance cues follows different principles than what was uncovered by overexpression of the Sec7 mutant. This notion is supported by the observation that over-expression of wild-type IQSEC3 did not lead to a statistically significant reduction in mismatched synapses, since mismatched synapses caused by other mechanisms might not be under the influence of IQSEC3 regulation. In vivo, IQSEC3 function might be restricted to synapses that are closely apposed to synapses employing a different neurotransmitter system. GABAergic synapses that are located on dendritic spines are often in close proximity to glutamatergic synapses and therefore IQSEC3 might be involved in the regulation of spine PSD nanodomains (Chen et al. 2012; van Versendaal et al. 2012) . Although complicated by high synaptic density in vivo, increased focus on synaptic mismatch in intact tissue might thus lead to a better understanding of the mechanisms underlying neurotransmitter-specific PSD regulation. On the one hand, IQSEC3 knockout mice will be instrumental in the elucidation of the physiological roles of IQSEC3. On the other hand, the development of in vivo models of synaptic mismatch would allow probing the involvement of genes required to correct misapposition, by designing rescue experiments. This might be achievable through blockade of neuronal activity, as mismatch of GABAergic terminals with glutamatergic postsynaptic structures was observed in Purkinje cells of TTXinfused cerebella (Cesa et al. 2008) , replicating the effects seen in the absence of GABA A R (Fritschy et al. 2006) . However, to the best of our knowledge, occurrence of postsynaptic GABAergic structures mis-apposed to glutamatergic axon terminals was not yet demonstrated in vivo.
Strikingly, in a post-mortem transcriptomic analysis of human cortex, IQSEC3 was found to be the gene which is most strongly down-regulated across schizophrenia, autism and bipolar disorder (Ellis et al. 2016) . Major issues that have to be addressed on the path to potential translational applications of our findings include the question of Arf subtype activation of human IQSEC3 and the uncertainty of mismatch-regulating mechanisms in vivo. So far, the physiological and behavioral consequences of receptor-transmitter mismatch in vivo are unexplored. However, in the light of association of IQSEC3 expression levels with major psychiatric disorders in humans, a role for synaptic mismatch in the etiology of these disorders should be considered in future investigations. Fig. 8 Analysis of IQSEC3 multimerization and neuronal somatic aggregation. (a) Capacity of IQSEC3 constructs to multimerize was assessed by co-IP of mCherry-tagged IQSEC3 with corresponding FLAG-tagged IQSEC3 variants. mCherry-tagged and FLAG-tagged IQSEC3 constructs were co-expressed in HEK293T cells, lysates were immunoprecipitated with anti-FLAG antibody and co-immunoprecipitation of mCherry-tagged constructs was assessed by immunoblotting with anti-mCherry antibody. As negative controls, only mCherry-tagged IQSEC3 was expressed (lane 1) and FLAG antibody was replaced by unspecific mouse IgG but both constructs were expressed (lane 2). Ratio of mCherry to FLAG immunoreactivity in immunoprecipitate was quantified. In all constructs mCherry-tagged variants were coimmunoprecipitated with FLAG-tagged variants. The mCherry to FLAG immunoprecipitate ratio was larger for IQSEC3 S348A than for wildtype IQSEC3. (b) Analysis of somatic aggregation of IQSEC3 in primary hippocampal neurons. Representative images and quantifications of somatic aggregates of FLAG-tagged IQSEC3 constructs are shown. Neuronal somata were blindly divided into cells containing small aggregates, large aggregates or both. Most cells over-expressing wild-type IQSEC3 contain small or large aggregates. The deletion of CC-domain containing N-terminus or mutation of IQ motif results in diffuse somatic distribution of IQSEC3 in most transfected cells. Small aggregates remain in IQSEC3 DN and large aggregates remain in IQ mutant. Over-expression of individual IQSEC3 domains is not sufficient for formation of somatic aggregates. *p < 0.05; (see Table 3 for results of statistical analyses).
